Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Sotorasib by Amgen for Metastatic Colorectal Cancer: Likelihood of Approval
Sotorasib is under clinical development by Amgen and currently in Pre-Registration for Metastatic Colorectal Cancer. According to GlobalData, Pre-Registration drugs...
Sotorasib by Amgen for Colorectal Cancer: Likelihood of Approval
Sotorasib is under clinical development by Amgen and currently in Pre-Registration for Colorectal Cancer. According to GlobalData, Pre-Registration drugs for...
Sotorasib by Amgen for Solid Tumor: Likelihood of Approval
Sotorasib is under clinical development by Amgen and currently in Phase II for Solid Tumor. According to GlobalData, Phase II...
Sotorasib by Amgen for Metastatic Pancreatic Cancer: Likelihood of Approval
Sotorasib is under clinical development by Amgen and currently in Phase I for Metastatic Pancreatic Cancer. According to GlobalData, Phase...
Sotorasib by Amgen for Colorectal Cancer: Likelihood of Approval
Sotorasib is under clinical development by Amgen and currently in Pre-Registration for Colorectal Cancer. According to GlobalData, Pre-Registration drugs for...